Solid biosciences announces organizational changes to prioritize development of sgt-001

Solid biosciences announces organizational changes to prioritize development of sgt-001.solid biosciences inc - as part of organizational changes, co will reduce its work force by approximately one third.solid biosciences - activities supporting co's other research and development programs will be curtailed as solid establishes a path forward for sgt-001.solid biosciences - corporate changes implemented will result in reduction in corporate expenses.solid biosciences - coo alvaro amorrortu & chief medical officer jorge quiroz will depart co.solid biosciences inc - corporate changes implemented are expected to extend cash runway into 2021.solid biosciences inc - will focus on conducting analyses of sgt-001 to determine how to address clinical hold & resume dosing.
SLDB Ratings Summary
SLDB Quant Ranking